Michael C Ezebuenyi
Overview
Explore the profile of Michael C Ezebuenyi including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
3
Citations
5
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Onor I, Ahmed F, Nguyen A, Ezebuenyi M, Obi C, Schafer A, et al.
Am J Med Sci
. 2023 Oct;
367(1):4-13.
PMID: 37832917
The rising prevalence of comorbidities in an increasingly aging population has sparked a reciprocal rise in polypharmacy. Patients with chronic kidney disease (CKD) have a greater burden of polypharmacy due...
2.
Onor I, Neuliep A, Tran K, Lambert J, Gillard C, Brakta F, et al.
Drugs R D
. 2020 Mar;
20(2):83-93.
PMID: 32166646
Background: Vancomycin empiric therapy is commonly dosed using clinical algorithms adapted from population-predicted pharmacokinetic parameters. However, precise dosing of vancomycin can be designed using patient-specific pharmacokinetic calculations. Objective: The objective...
3.
Ezebuenyi M, Brakta F, Onor I, Sarpong D, Bryant-Burks K, Figueroa 2nd J
P T
. 2018 May;
43(5):287-292.
PMID: 29719370
Purpose: Skin and soft tissue infections (SSTIs) cause about 15 million cases of infection that result in more than 869,000 annual hospitalizations in the United States. Cellulitis accounted for 63%...